Effect of high-dose chemotherapy on intestinal permeability in humans

Clinical Science

Volumn 92, Issue 4, 1997, Pages 385-389

  Keefe, D M K ^a   Cummins, A G ^a   Dale, B M ^a   Kotasek, D ^a   Robb, T A ^b   Sage, R E ^a  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

^b WOMEN S AND CHILDREN S HOSPITAL   (Australia)

Author keywords

Chemotherapy; Intestinal permeability; Mucositis

Indexed keywords

BUSULFAN; CARBOPLATIN; CYCLOPHOSPHAMIDE; EPIRUBICIN; LACTULOSE; MELPHALAN; RHAMNOSE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; DIARRHEA; DISEASE SEVERITY; DRUG ABSORPTION; DRUG PENETRATION; FEMALE; HUMAN; INTESTINE ABSORPTION; INTESTINE INJURY; INTESTINE MUCOSA PERMEABILITY; MALE; MUCOSA INFLAMMATION; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SMALL INTESTINE; STEM CELL TRANSPLANTATION; TIGHT JUNCTION; VOMITING;

EID: 0030933261     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0920385     Document Type: Article

References (16)

1. Sonis ST. Oral complications. Complications of cancer and their treatment. In: Cancer Medicine, 3rd Edition. Philadelphia. London: Lea & Febiger, 1993: 2381-88.
2. Cummins AG, Penttila IA, LaBrooy JT, Robb TA, Davidson GP. Recovery of the small intestine in coeliac disease on a gluten-free diet: changes in intestinal permeability, small bowel morphology and T-cell activity. J Gastroenterol Hepatol 1991;6:53-57.
3. Menzies IS, Turner MW. Intestinal permeation of molecules in health and disease. In: MacDonald TT, ed. Immunology of gastrointestinal disease. Immunology and Medicine Series. vol. 19. London: Kluwer Academic Publishers, 1992; 173-91:
4. Bjarnason, I. Intestinal permeability. Gut 1994. I (Suppl): S18-S22.
5. Bijlsma PB, Peeters RA, Groot JA, Dekker PR, Taminiau JAJM, Van der Meer R. Differential in vivo and in vitro intestinal permeability to lactulose and mannitol in animals and humans: a hypothesis. Gastroenterology 1995; 108: 687-696.
6. Franklin HR, Simonetti GPC, Dubbelman AC, et al. Toxicity grading systems. A comparison between the WHO scoring system and the Common Toxicity Criteria when used for nausea and vomiting. Ann Oncol 1994; 5: 113-17.
7. Harper JF, Peritz' F test. BASIC program of a robust multiple comparison test for statistical analysis of all differences among group means. Comput Biol Med 1984; 14: 437-45.
8. Parrili G, Iaffaioli RV, Martorano M, et al. Effects of anthracycline therapy on intestinal absorption in patients with advanced breast cancer. Cancer Res. 1989; 49: 3689-91.
9. Pledger JV, Pearson ADJ, Craft AW, Laker MF, Eastham EJ. Intestinal permeability during chemotherapy for childhood tumours. Eur J Pediatr 1988; 147: 123-7.
10. Smith FP, Kisner DL, Widerlite L, Schein PS. Chemotherapeutic alteration of small intestinal morphology and function: a progress report. J Clin Gastroenterol 1979; 1: 203-7.
11. Forbes GM, Rule SAJ, Herrmann RP, Davies JM, Collins BJ. A prospective study of screening upper gastrointestinal endoscopy prior to and after bone marrow transplantation. Aust NZ J Med 1995; 25: 32-6.
12. Kaw M, Przepiorka D, Sekas G. Infectious complications of endoscopic procedures in bone marrow transplant recipients. Dig Dis Sci 1993; 38: 71-4.
13. Taminiau JAJM, Gall DG, Hamilton JR, Response of the rat small intestine epithelium to methotrexate. Gut 1980; 21: 486-92.
14. Trier JS. Morphologic alterations induced by methotrexate in the mucosa of the proximal small intestine. I. Serial observations by light microscopy. Gastroenterology 1962; 42: 295-305.
15. Juby LD, Dixon MF, Axon ATR. Abnormal intestinal permeability and jejunal morphometry. J Clin Pathol 1987; 40: 714-8.
16. Fine KD, Santa Ana CA, Porter JL, Fordtran JS. Effect of changing intestinal flow rate on a measurement of intestinal permeability. Gastroenterology 1995; 108: 983-9.